Evidence map›Paper›PMID 41852764›Full record

ArticleJournal of vascular surgery cases and innovative techniques2026

Etiology and management outcomes of inferior mesenteric artery aneurysm.

Elizabeth Mya Akfaly, Niraj Balakrishnan, Jacob Baxter, Anirudh Vemulapalli, Carly Brovold, Zachary Osborne, Jason Beckermann, Tahlia Weis, Indrani Sen

Abstract read
In one paragraph

Article in Journal of vascular surgery cases and innovative techniques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Endovascular repair of a giant inferior mesenteric artery aneurysm.Journal of vascular surgery cases and innovative techniques · 2026
    Article
  2. Reply.Journal of vascular surgery cases and innovative techniques · 2026
    Article
  3. Hemodynamic and patient-level considerations in inferior mesenteric artery aneurysm management.Journal of vascular surgery cases and innovative techniques · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elizabeth Mya AkfalyVascular and Endovascular Surgery, Mayo Clinic Health System, Eau Claire, WI.
Niraj BalakrishnanVascular and Endovascular Surgery, Mayo Clinic Health System, Eau Claire, WI.
Jacob BaxterVascular and Endovascular Surgery, Mayo Clinic Health System, Eau Claire, WI.
Anirudh VemulapalliVascular and Endovascular Surgery, Mayo Clinic Health System, Eau Claire, WI.
Carly BrovoldVascular and Endovascular Surgery, Mayo Clinic Health System, Eau Claire, WI.
Zachary OsborneVascular and Endovascular Surgery, Mayo Clinic Health System, Eau Claire, WI.
Jason BeckermannVascular and Endovascular Surgery, Mayo Clinic Health System, Eau Claire, WI.
Tahlia WeisVascular and Endovascular Surgery, Mayo Clinic Health System, Eau Claire, WI.
Indrani SenVascular and Endovascular Surgery, Mayo Clinic Health System, Eau Claire, WI.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Inferior mesenteric artery aneurysms (IMAAs) are extremely rare, and their natural history and treatment outcomes are poorly understood. Methods: We performed a retrospective review of consecutive patients with IMAAs treated at a multistate health system between November 2005 and August 2025. Demographics, etiology, imaging features, treatment, and outcomes were analyzed. Results: There were 15 patients (11 male; mean age, 66 ± 15 years), and all these patients were diagnosed on computed tomography angiography. Presentation was with nonspecific abdominal pain in nine patients (88%), symptomatic chronic mesenteric ischemia in one patient (6%), and shock owing to rupture in one patient (6%). The most common etiology was segmental arterial mediolysis (SAM) (n = 9 [60%]), followed by atherosclerosis (n = 6 [40%]). Ten patients (67%) were managed nonoperatively, and in these patients the mean IMAA diameter was 0.9 ± .4 cm. Over a median imaging follow-up of 42 months (range, 10-170 months), size remained stable with a mean IMAA diameter of 0.9 ± 0.4 cm. Surgical intervention was required in five patients (33%; mean IMAA diameter, 2.1 ± 0.4 cm). All three patients (20%) with atherosclerosis and celiomesenteric occlusion had an IMAA of >1.5 cm, consistent with poststenotic jet flow phenomenon. Indication for repair included IMAA enlargement to >2 cm, with symptomatic chronic mesenteric ischemia in one patient (6%). Procedures performed included aneurysm resection with aorta to IMA bypass with Dacron graft (n = 1), supraceliac aorta to celiac and superior mesenteric artery bypass with IMA aneurysmorrhaphy, and endovascular repair (covered stent placement, n = 1). In two patients (13%), the celiac and superior mesenteric artery were patent, and the IMAA was ligated (diagnosis at presentation with shock owing to IMAA rupture, etiology unknown; colectomy for recurrent diverticulitis and SAM with a 1.6-cm IMAA). There were no major postoperative complications or aneurysm-related death. At a median clinical follow-up of 50 months, two patients had died with a cause of death unrelated to IMAA. Conclusions: Inferior mesenteric aneurysms secondary to SAM are usually smaller at presentation and have a benign course. IMAA associated with celiomesenteric occlusion experience progressive enlargement owing to jet phenomenon hemodynamics and require repair. Repair is required for rupture or when the aneurysm diameter reaches ≥1.5 cm if the celiac and superior mesenteric artery inflow are intact.

Indexed as

AneurysmCeliomesenteric occlusionEndovascular repairHemodynamic mechanismInferior mesenteric artery aneurysmPost-stenotic dilationRupture risk

Identifiers

PMID41852764
PMCPMC12995487

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.